Chemokine receptor antagonist (CRA) drugs such as maraviroc (CCR5 antagonist) or plerixafor (CXCR4 antagonist) have shown a role in the suppression of cancer cell proliferation, migration, and metastasis [18,19]. Here, CXCR4 is linked to cancer.